Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin + dexamethasone + ropivacaine for post-tonsillectomy pain in adults
IRCT20100127003213N10Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin, dexamethasone and ropivacaine in tonsillitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain. Started Jun 2023; status: completed.
02
Drugs
gabapentindexamethasoneropivacaine
03
Conditions
tonsillitis
Beyond the preview
Go deeper on IRCT20100127003213N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003213N10.